Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

BCABBioAtla, Inc.

OTC · CIK 0001826892
Filer categoryNon-accelerated filer<br>Smaller reporting company
Entity typeoperating
SIC2836 Biological Products, (No Diagnostic Substances)
FY end1231
XBRL facts245

Identity from submissions API

NameBioAtla, Inc.
CIK0001826892
TickersBCAB
ExchangesOTC
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company
SIC2836 Biological Products, (No Diagnostic Substances)
EIN851922320
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone858-558-0708
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • None listed.
Business address
11085 TORREYANA ROAD
SAN DIEGO
CA
92121
CA
Mailing address
11085 TORREYANA ROAD
SAN DIEGO
CA
92121
CA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

510 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-16 10-Q 10-Q 0001193125-26-462306 001-39787 261555885 34 9715379 1 1
2026-10-29 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-003378 333-299532 261504254 33 1711
2026-10-29 424B3 424B3 0001539497-26-002803 333-299532 261502922 33 2768722
2026-10-27 RW RW 0001539497-26-002776 333-292784 261491820 NE 19843
2026-10-20 S-1 S-1 0001539497-26-002711 333-299532 261470362 33 11804246 1 1
2026-10-20 8-K 8-K 1.01,1.02,3.02,9.01 0001193125-26-425553 001-39787 261470347 34 898918 1 1
2026-09-29 8-K 8-K 5.02,9.01 0001193125-26-407817 001-39787 261424808 34 306325 1 1
2026-09-02 4 4 0001193125-26-380486 4863
2026-09-02 4 4 0001193125-26-380482 8799
2026-09-02 4 4 0001193125-26-380479 4969
2026-08-28 8-K FORM 8-K 3.01 0001539497-26-002373 001-39787 261333005 34 195825 1 1
2026-08-13 10-Q 10-Q 0001193125-26-349542 001-39787 261274688 34 9477669 1 1
2026-07-16 8-K 8-K 5.07 0001193125-26-306117 001-39787 261180507 34 166847 1 1
2026-06-05 4 4 0001193125-26-259699 6605
2026-06-05 4 4 0001193125-26-259702 10833
2026-06-05 4 4 0001193125-26-259689 6629
2026-06-03 ARS ARS 0001193125-26-255438 001-39787 261060697 34 12226603
2026-06-03 DEFA14A DEFA14A 0001193125-26-255434 001-39787 261060676 34 2880863
2026-06-03 DEF 14A DEF 14A 0001193125-26-255422 001-39787 261060643 34 6583097 1 1
2026-05-15 10-Q 10-Q 0001193125-26-226631 001-39787 26987054 34 8046732 1 1
2026-04-29 10-K/A 10-K/A 0001193125-26-191493 001-39787 26915822 34 3418200 1 1
2026-04-02 8-K 8-K 8.01,9.01 0001193125-26-140053 001-39787 26833282 34 179400 1 1
2026-03-31 S-8 S-8 0001193125-26-134492 333-294789 26822966 33 847511 1 1
2026-03-31 10-K 10-K 0001193125-26-134499 001-39787 26821649 34 11823255 1 1
2026-03-31 8-K 8-K 2.02,7.01 0001193125-26-134501 001-39787 26821637 34 35563172 1 1
2026-03-23 8-K 8-K 5.02,5.07 0001193125-26-119698 001-39787 26782132 34 169556 1 1
2026-03-20 424B2 424B2 0001539497-26-000972 333-269148 26778241 33 107535
2026-03-13 424B2 PROSPECTUS SUPPLEMENT NO. 2 0001539497-26-000924 333-269148 26752431 33 107699
2026-03-12 4 4 0001193125-26-104136 4841
2026-03-12 4 4 0001193125-26-104134 8786
2026-03-12 4 4 0001193125-26-104132 4818
2026-03-09 424B2 424B2 0001539497-26-000894 333-269148 26732640 33 107294
2026-03-02 4 4 0001193125-26-085971 8673
2026-03-02 4 4 0001193125-26-085970 4705
2026-03-02 4 4 0001193125-26-085968 4822
2026-03-02 4 4 0001193125-26-085966 4728
2026-03-02 DEFA14A DEFA14A 0001539497-26-000813 001-39787 26703507 34 345483
2026-03-02 8-K FORM 8-K 2.02,2.05,5.02,7.01,8.01,9.01 0001539497-26-000812 001-39787 26703505 34 275062 1 1
2026-02-11 DEFM14A DEFM14A 0001539497-26-000331 001-39787 26620673 34 514267
2026-02-09 8-K 8-K 8.01 0001193125-26-041852 001-39787 26609441 34 140979 1 1
2026-02-06 8-K 8-K 3.01,7.01 0001193125-26-041367 001-39787 26608627 34 166220 1 1
2026-01-30 PREM14A PREM14A 0001539497-26-000230 001-39787 26584511 34 2457479
2026-01-30 8-K 8-K 5.03,5.07,7.01,8.01,9.01 0001193125-26-031942 001-39787 26584061 34 341287 1 1
2026-01-16 S-3 S-3 0001193125-26-015344 333-292784 26539479 33 1365282 1 1
2026-01-15 DEFA14A DEFA14A 0001193125-26-013845 001-39787 26535581 34 536376
2026-01-12 8-K 8-K 3.02,5.03,5.07,8.01,9.01 0001193125-26-010458 001-39787 26527057 34 205923 1 1
2025-12-31 DEFA14A DEFA14A 0001193125-25-338402 001-39787 251617964 34 17077
2025-12-31 8-K 8-K 1.01,3.02,7.01,9.01 0001193125-25-337646 001-39787 251615728 34 186406 1 1
2025-12-30 8-K 8-K 5.07,8.01 0001193125-25-337078 001-39787 251614290 34 166678 1 1
2025-12-05 DEF 14A DEF 14A 0001539497-25-003176 001-39787 251552940 34 3619185
2025-12-01 4 4 0001193125-25-304178 4893
2025-12-01 4 4 0001193125-25-304173 4733
2025-12-01 4 4 0001193125-25-304171 8677
2025-12-01 4 4 0001193125-25-304170 4828
2025-11-24 PRE 14A PRE 14A 0001193125-25-292058 001-39787 251509619 34 381917
2025-11-21 424B5 424B5 0001193125-25-290676 333-269148 251504682 33 579324
2025-11-21 8-K 8-K 1.01,2.03,9.01 0001193125-25-290474 001-39787 251504543 34 1709308 1 1
2025-11-13 10-Q 10-Q 0001193125-25-280435 001-39787 251479565 34 8356062 1 1
2025-11-13 8-K 8-K 2.02,9.01 0001193125-25-280141 001-39787 251478385 34 343808 1 1
2025-10-15 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0002060873-25-000004 005-91930 251393490 34 7160
2025-09-22 8-K 8-K 8.01 0001193125-25-211305 001-39787 251330127 34 150237 1 1
2025-09-02 4 4 0000950170-25-112618 8678
2025-09-02 4 4 0000950170-25-112616 4785
2025-09-02 4 4 0000950170-25-112615 4734
2025-09-02 4 4 0000950170-25-112614 4764
2025-08-07 10-Q 10-Q 0000950170-25-105220 001-39787 251195160 34 9384619 1 1
2025-08-07 8-K 8-K 2.02,9.01 0000950170-25-105000 001-39787 251193953 34 327600 1 1
2025-06-20 8-K 8-K 5.02,5.07 0000950170-25-088499 001-39787 251061373 34 176043 1 1
2025-06-18 4 4 0000950170-25-088065 4701
2025-06-18 4 4 0000950170-25-088064 4723
2025-06-18 4 4 0000950170-25-088063 4850
2025-06-18 4 4 0000950170-25-088062 4711
2025-06-18 4 4 0000950170-25-088061 4611
2025-06-18 4 4 0000950170-25-088060 4747
2025-06-03 4 4 0000950170-25-080994 8679
2025-06-03 4 4 0000950170-25-080990 4733
2025-06-03 4 4 0000950170-25-080991 4898
2025-06-03 4 4 0000950170-25-080980 4919
2025-05-20 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001636587-25-000025 005-91930 25967932 34 11990
2025-05-16 8-K 8-K 3.01 0000950170-25-073688 001-39787 25960395 34 157736 1 1
2025-05-16 424B3 424B3 0001193125-25-121711 333-287011 25959620 33 125253
2025-05-14 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-001604 333-287011 25948282 33 1710
2025-05-12 CORRESP filename1.htm 0001193125-25-117883 14624
2025-05-09 UPLOAD filename1.pdf 0000000000-25-004982 333-287011 40065
2025-05-06 S-3 S-3 0001193125-25-113919 333-287011 25918379 33 229572
2025-05-06 10-Q 10-Q 0000950170-25-064594 001-39787 25918160 34 7134918 1 1
2025-05-06 8-K 8-K 2.02,9.01 0000950170-25-064415 001-39787 25917093 34 311064 1 1
2025-04-25 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000902664-25-001988 005-91930 25872415 34 9459
2025-04-24 ARS ARS 0000950170-25-058047 001-39787 25867459 34 2144638
2025-04-24 DEFA14A DEFA14A 0000950170-25-058024 001-39787 25867380 34 1305718
2025-04-24 DEF 14A DEF 14A 0000950170-25-058011 001-39787 25867308 34 5563980 1 1
2025-03-28 S-8 S-8 0000950170-25-046227 333-286196 25781282 33 666462
2025-03-28 10-K 10-K 0000950170-25-046217 001-39787 25780785 34 10797884 1 1
2025-03-27 8-K 8-K 2.02,2.05,9.01 0000950170-25-046065 001-39787 25779342 34 334312 1 1
2025-03-18 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0002060873-25-000001 005-91930 25747096 34 7411
2025-03-14 8-K 8-K 5.02 0000950170-25-039400 001-39787 25739924 34 154680 1 1
2025-03-13 4 4 0000950170-25-038748 4874
2025-03-13 4 4 0000950170-25-038746 8769
2025-03-13 4 4 0000950170-25-038745 4853
2025-03-13 4 4 0000950170-25-038741 4823
2025-02-24 4 4 0000950170-25-025969 8683
2025-02-24 4 4 0000950170-25-025968 4739
2025-02-24 4 4 0000950170-25-025967 4904
2025-02-24 4 4 0000950170-25-025962 4924
2025-02-10 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000902664-25-000807 005-91930 25606532 34 10603
2025-02-07 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000950170-25-016381 005-91930 25602512 34 9882
2025-02-07 8-K 8-K 3.01 0000950170-25-016321 001-39787 25602165 34 153156 1 1
2025-01-24 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-005973 005-91930 25554095 34 15168
2024-12-20 424B5 424B5 0001193125-24-283216 333-262528 241568712 33 489813
2024-12-20 8-K 8-K 1.01,7.01,9.01 0001193125-24-283212 001-39787 241568660 34 531331 1 1
2024-12-20 8-K 8-K 7.01,9.01 0001193125-24-282547 001-39787 241565297 34 17919087 1 1
2024-11-14 SC 13G/A AMENDMENT NO. 3 0001214659-24-019104 005-91930 241461363 34 84008
2024-11-07 10-Q 10-Q 0000950170-24-123506 001-39787 241436942 34 6080620 1 1
2024-11-07 8-K 8-K 2.02,9.01 0000950170-24-123281 001-39787 241435501 34 303188 1 1
2024-10-02 SC 13D/A AMENDMENT NO. 6 TO SCHEDULE 13D 0001213900-24-084675 005-91930 241347862 34 175326
2024-09-23 8-K 8-K 1.01,9.01 0001193125-24-223282 001-39787 241314647 34 1035281 1 1
2024-09-06 SC 13D/A AMENDMENT NO. 5 TO SCHEDULE 13D 0001213900-24-076577 005-91930 241285108 34 178739
2024-09-03 4 4 0000950170-24-102925 4720
2024-09-03 4 4 0000950170-24-102924 4738
2024-08-08 10-Q 10-Q 0000950170-24-094164 001-39787 241189445 34 5935967 1 1
2024-08-08 8-K 8-K 2.02,9.01 0000950170-24-093888 001-39787 241188149 34 292959 1 1
2024-08-07 SC 13G BCAB_SC13G.htm 0001273087-24-000082 005-91930 241184221 34 81716
2024-08-01 4 4 0000950170-24-089427 4720
2024-08-01 4 4 0000950170-24-089419 4738
2024-07-08 SC 13G/A us09077b1044_070824.txt 0001086364-24-008160 005-91930 241105158 34 12752
2024-07-01 4 4 0000950170-24-079916 4720
2024-07-01 4 4 0000950170-24-079915 4738
2024-06-14 4 4 0000950170-24-073683 4718
2024-06-14 4 4 0000950170-24-073681 4618
2024-06-14 4 4 0000950170-24-073678 4757
2024-06-14 4 4 0000950170-24-073675 4857
2024-06-14 4 4 0000950170-24-073662 4731
2024-06-14 4 4 0000950170-24-073659 4708
2024-06-13 8-K 8-K 5.07 0000950170-24-073139 001-39787 241042121 34 158700 1 1
2024-05-31 4 4 0000950170-24-067579 4720
2024-05-31 4 4 0000950170-24-067577 4738
2024-05-17 8-K 8-K 8.01 0000950170-24-061616 001-39787 24959540 34 147535 1 1
2024-05-14 10-Q 10-Q 0000950170-24-059757 001-39787 24945515 34 5532181 1 1
2024-05-14 8-K 8-K 2.02,9.01 0000950170-24-059508 001-39787 24944196 34 274334 1 1
2024-05-01 4 4 0000950170-24-051521 4737
2024-05-01 4 4 0000950170-24-051520 4719
2024-04-24 8-K 8-K 5.03,9.01 0000950170-24-047595 001-39787 24870753 34 446061 1 1
2024-04-24 ARS ARS 0000950170-24-047582 001-39787 24870650 34 997447
2024-04-24 DEFA14A DEFA14A 0000950170-24-047568 001-39787 24870539 34 1418928
2024-04-24 DEF 14A DEF 14A 0000950170-24-047562 001-39787 24870499 34 2874113
2024-04-16 SC 13D/A AMENDMENT NO. 4 TO SCHEDULE 13D 0001213900-24-033175 005-91930 24846235 34 180267
2024-04-01 4 4 0000950170-24-039480 4719
2024-04-01 4 4 0000950170-24-039478 4737
2024-03-26 S-8 S-8 0000950170-24-036571 333-278247 24784679 33 601016
2024-03-26 10-K 10-K 0000950170-24-036548 001-39787 24784543 34 9197336 1 1
2024-03-26 8-K 8-K 2.02,9.01 0000950170-24-036395 001-39787 24783428 34 302073 1 1
2024-03-01 4 FORM 4 SUBMISSION 0001209191-24-004161 4947
2024-03-01 4 FORM 4 SUBMISSION 0001209191-24-004156 4965
2024-02-21 8-K 8-K 5.02 0000950170-24-017881 001-39787 24659272 34 162056 1 1
2024-02-20 4 FORM 4 SUBMISSION 0001209191-24-003511 5057
2024-02-20 4 FORM 4 SUBMISSION 0001209191-24-003509 5063
2024-02-20 4 FORM 4 SUBMISSION 0001209191-24-003508 5027
2024-02-20 4 FORM 4 SUBMISSION 0001209191-24-003507 8973
2024-02-14 SC 13G/A AMENDMENT NO. 2 0001214659-24-002863 005-91930 24637363 34 84571
2024-02-12 8-K 8-K 8.01 0000950170-24-013807 001-39787 24619757 34 153163 1 1
2024-02-09 SC 13G/A BIOATLA, INC. JAY SHORT 13G/A 0001068238-24-000042 005-91930 24615880 34 74513
2024-02-06 SC 13G/A BIOATLA, INC. 0000902664-24-001098 005-91930 24600054 34 99339
2024-02-01 4 FORM 4 SUBMISSION 0001209191-24-002594 4947
2024-02-01 4 FORM 4 SUBMISSION 0001209191-24-002592 4964
2024-01-29 SC 13G us09077b1044_012924.txt 0001086364-24-005524 005-91930 24574931 34 13226
2024-01-19 4 FORM 4 SUBMISSION 0001209191-24-001929 4426
2024-01-09 8-K 8-K 7.01,9.01 0001193125-24-004912 001-39787 24521902 34 17735686 1 1
2024-01-08 8-K 8-K 5.03,9.01 0001193125-24-004539 001-39787 24521006 34 321781 1 1
2024-01-03 4 FORM 4 SUBMISSION 0001209191-24-000603 5046
2024-01-03 4 FORM 4 SUBMISSION 0001209191-24-000601 5033
2024-01-03 4 FORM 4 SUBMISSION 0001209191-24-000598 4947
2024-01-03 4 FORM 4 SUBMISSION 0001209191-24-000596 4964
2023-12-26 4 FORM 4 SUBMISSION 0001209191-23-059720 4802
2023-12-20 4 FORM 4 SUBMISSION 0001209191-23-059387 8908
2023-12-19 4 FORM 4 SUBMISSION 0001209191-23-059284 5043
2023-12-19 4 FORM 4 SUBMISSION 0001209191-23-059164 5129
2023-12-13 8-K 8-K 7.01,8.01,9.01 0001193125-23-293959 001-39787 231483043 34 190319 1 1
2023-12-04 8-K 8-K 8.01,9.01 0001193125-23-288019 001-39787 231461463 34 2792830 1 1
2023-12-01 4 FORM 4 SUBMISSION 0001209191-23-057086 4866
2023-12-01 4 FORM 4 SUBMISSION 0001209191-23-057084 4883
2023-11-07 10-Q 10-Q 0000950170-23-060389 001-39787 231384981 34 6591990 1 1
2023-11-07 8-K 8-K 2.02,9.01 0000950170-23-060210 001-39787 231383563 34 334575 1 1
2023-11-02 4 FORM 4 SUBMISSION 0001209191-23-054075 8831
2023-11-02 4 FORM 4 SUBMISSION 0001209191-23-054073 4914
2023-11-01 4 FORM 4 SUBMISSION 0001209191-23-054063 4883
2023-11-01 4 FORM 4 SUBMISSION 0001209191-23-054062 4866
2023-11-01 4 FORM 4 SUBMISSION 0001209191-23-054061 4917
2023-10-03 4 FORM 4 SUBMISSION 0001209191-23-051692 4965
2023-10-03 4 FORM 4 SUBMISSION 0001209191-23-051691 4952
2023-10-02 4 FORM 4 SUBMISSION 0001209191-23-051187 8831
2023-10-02 4 FORM 4 SUBMISSION 0001209191-23-051184 4914
2023-10-02 4 FORM 4 SUBMISSION 0001209191-23-051182 4917
2023-10-02 4 FORM 4 SUBMISSION 0001209191-23-051180 4866
2023-10-02 4 FORM 4 SUBMISSION 0001209191-23-051178 4883
2023-09-13 4 FORM 4 SUBMISSION 0001209191-23-049347 4345
2023-09-01 4 FORM 4 SUBMISSION 0001209191-23-048035 5049
2023-09-01 4 FORM 4 SUBMISSION 0001209191-23-048034 4917
2023-09-01 4 FORM 4 SUBMISSION 0001209191-23-048033 4866
2023-09-01 4 FORM 4 SUBMISSION 0001209191-23-048032 4883
2023-09-01 4 FORM 4 SUBMISSION 0001209191-23-048031 8831
2023-08-01 4 FORM 4 SUBMISSION 0001209191-23-044052 8831
2023-08-01 4 FORM 4 SUBMISSION 0001209191-23-044051 5049
2023-08-01 4 FORM 4 SUBMISSION 0001209191-23-044049 5018
2023-08-01 4 FORM 4 SUBMISSION 0001209191-23-044048 4866
2023-08-01 4 FORM 4 SUBMISSION 0001209191-23-044046 4917
2023-08-01 10-Q 10-Q 0000950170-23-036554 001-39787 231132621 34 7388458 1 1
2023-08-01 8-K 8-K 2.02,9.01 0000950170-23-036440 001-39787 231131556 34 372153 1 1
2023-07-05 4 FORM 4 SUBMISSION 0001209191-23-041218 4952
2023-07-05 4 FORM 4 SUBMISSION 0001209191-23-041217 4964
2023-07-03 4 FORM 4 SUBMISSION 0001209191-23-040669 8831
2023-07-03 4 FORM 4 SUBMISSION 0001209191-23-040667 4917
2023-07-03 4 FORM 4 SUBMISSION 0001209191-23-040666 4866
2023-07-03 4 FORM 4 SUBMISSION 0001209191-23-040664 4883
2023-07-03 4 FORM 4 SUBMISSION 0001209191-23-040662 4914
2023-06-15 4 FORM 4 SUBMISSION 0001209191-23-037549 7683
2023-06-15 4 FORM 4 SUBMISSION 0001209191-23-037548 5422
2023-06-15 4 FORM 4 SUBMISSION 0001209191-23-037547 5399
2023-06-15 4 FORM 4 SUBMISSION 0001209191-23-037546 5548
2023-06-15 4 FORM 4 SUBMISSION 0001209191-23-037545 5309
2023-06-15 4 FORM 4 SUBMISSION 0001209191-23-037544 5409
2023-06-14 8-K 8-K 5.07 0000950170-23-028007 001-39787 231014865 34 186063 1 1
2023-06-01 4 FORM 4 SUBMISSION 0001209191-23-033473 8830
2023-06-01 4 FORM 4 SUBMISSION 0001209191-23-033472 4913
2023-06-01 4 FORM 4 SUBMISSION 0001209191-23-033471 4882
2023-06-01 4 FORM 4 SUBMISSION 0001209191-23-033470 4865
2023-06-01 4 FORM 4 SUBMISSION 0001209191-23-033469 4916
2023-05-15 4 FORM 4 SUBMISSION 0001209191-23-029632 4962
2023-05-15 4 FORM 4 SUBMISSION 0001209191-23-029631 4951
2023-05-11 10-Q 10-Q 0000950170-23-021358 001-39787 23912005 34 6256772 1 1
2023-05-11 8-K 8-K 2.02,9.01 0000950170-23-021212 001-39787 23910952 34 347906 1 1
2023-05-02 4 FORM 4 SUBMISSION 0001209191-23-026662 8830
2023-05-02 4 FORM 4 SUBMISSION 0001209191-23-026660 4913
2023-05-02 4 FORM 4 SUBMISSION 0001209191-23-026659 4882
2023-05-02 4 FORM 4 SUBMISSION 0001209191-23-026658 4865
2023-05-02 4 FORM 4 SUBMISSION 0001209191-23-026656 4916
2023-04-27 SC 13G BIOATLA, INC. 0000902664-23-002714 005-91930 23853706 34 111640
2023-04-24 DEFA14A DEFA14A 0000950170-23-014139 001-39787 23840924 34 1853392
2023-04-24 ARS ARS 0000950170-23-014137 001-39787 23840916 34 2513126
2023-04-24 DEF 14A DEF 14A 0000950170-23-014136 001-39787 23840905 34 3117257
2023-04-03 4 FORM 4 SUBMISSION 0001209191-23-022431 8830
2023-04-03 4 FORM 4 SUBMISSION 0001209191-23-022430 4913
2023-04-03 4 FORM 4 SUBMISSION 0001209191-23-022428 4882
2023-04-03 4 FORM 4 SUBMISSION 0001209191-23-022427 4923
2023-04-03 4 FORM 4 SUBMISSION 0001209191-23-022426 4916
2023-03-30 4 FORM 4 SUBMISSION 0001209191-23-021720 8824
2023-03-29 4 FORM 4 SUBMISSION 0001209191-23-021543 4912
2023-03-23 S-8 S-8 0000950170-23-009555 333-270802 23757090 33 720869
2023-03-23 10-K 10-K 0000950170-23-009551 001-39787 23757003 34 10832067 1 1
2023-03-23 8-K 8-K 2.02,9.01 0000950170-23-009469 001-39787 23756140 34 431758 1 1
2023-03-10 8-K 8-K 7.01 0000950170-23-007213 001-39787 23723137 34 161165 1 1
2023-03-01 4 FORM 4 SUBMISSION 0001209191-23-014295 11401
2023-03-01 4 FORM 4 SUBMISSION 0001209191-23-014294 7494
2023-03-01 4 FORM 4 SUBMISSION 0001209191-23-014292 7484
2023-03-01 4 FORM 4 SUBMISSION 0001209191-23-014290 7479
2023-03-01 4 FORM 4 SUBMISSION 0001209191-23-014288 7453
2023-02-27 SC 13G/A BIOATLA - JAY SHORT SCHEDULE 13G/A 0001068238-23-000043 005-91930 23675036 34 75294
2023-02-27 8-K 8-K 5.02,9.01 0001193125-23-049760 001-39787 23670167 34 160582 1 1
2023-02-15 8-K 8-K 5.02 0000950170-23-002910 001-39787 23635788 34 182747 1 1
2023-02-14 SC 13G/A AMENDMENT NO. 1 0001214659-23-002392 005-91930 23628396 34 84592
2023-02-14 SC 13G/A schedule13ga.htm 0000929638-23-000564 005-91930 23627758 34 106089
2023-02-09 SC 13G/A SCHEDULE 13G/A 0001104659-23-015457 005-91930 23602636 34 12886
2023-02-06 SC 13G/A SEC SCHEDULE 13G 0000846087-23-000082 005-91930 23590074 34 32760
2023-02-02 4 FORM 4 SUBMISSION 0001209191-23-006438 8798
2023-02-02 4 FORM 4 SUBMISSION 0001209191-23-006435 4882
2023-02-02 4 FORM 4 SUBMISSION 0001209191-23-006433 4884
2023-02-02 4 FORM 4 SUBMISSION 0001209191-23-006430 4850
2023-02-02 4 FORM 4 SUBMISSION 0001209191-23-006424 4876
2023-01-17 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2023-01-17 16:00:00 9999999995-23-000119 333-269148 23532845 33 1668
2023-01-13 CORRESP filename1.htm 0001193125-23-008334 13319
2023-01-13 UPLOAD filename1.pdf 0000000000-23-000388 40122
2023-01-09 SC 13D/A SC 13D/A 0001193125-23-004819 005-91930 23518758 34 159751
2023-01-06 S-3 S-3 0001193125-23-003572 333-269148 23515337 33 852467
2023-01-06 8-K 8-K 1.01,9.01 0001193125-23-003550 001-39787 23515215 34 424476 1 1
2023-01-06 424B5 424B5 0001193125-23-003545 333-262528 23515174 33 311835
2023-01-03 4 FORM 4 SUBMISSION 0001209191-23-000323 8798
2023-01-03 4 FORM 4 SUBMISSION 0001209191-23-000318 4884
2023-01-03 4 FORM 4 SUBMISSION 0001209191-23-000316 4881
2023-01-03 4 FORM 4 SUBMISSION 0001209191-23-000311 4850
2023-01-03 4 FORM 4 SUBMISSION 0001209191-23-000305 4876
2022-12-19 4 FORM 4 SUBMISSION 0001209191-22-062000 4314
2022-12-01 4 FORM 4 SUBMISSION 0001209191-22-059271 8800
2022-12-01 4 FORM 4 SUBMISSION 0001209191-22-059269 5018
2022-12-01 4 FORM 4 SUBMISSION 0001209191-22-059265 4987
2022-12-01 4 FORM 4 SUBMISSION 0001209191-22-059264 4886
2022-12-01 4 FORM 4 SUBMISSION 0001209191-22-059263 5013
2022-11-23 4 FORM 4 SUBMISSION 0001209191-22-058723 4314
2022-11-07 8-K 8-K 1.01,9.01 0001193125-22-279214 001-39787 221366327 34 420386 1 1
2022-11-07 424B5 424B5 0001193125-22-278766 333-262528 221364417 33 359454
2022-11-04 8-K 8-K 8.01,9.01 0001193125-22-277328 001-39787 221360054 34 3324528 1 1
2022-11-04 10-Q 10-Q 0000950170-22-022036 001-39787 221360048 34 8140603 1 1
2022-11-03 8-K 8-K 2.02,9.01 0000950170-22-021833 001-39787 221357845 34 397645 1 1
2022-11-01 4 FORM 4 SUBMISSION 0001209191-22-055169 8799
2022-11-01 4 FORM 4 SUBMISSION 0001209191-22-055168 4882
2022-11-01 4 FORM 4 SUBMISSION 0001209191-22-055167 4851
2022-11-01 4 FORM 4 SUBMISSION 0001209191-22-055166 4885
2022-11-01 4 FORM 4 SUBMISSION 0001209191-22-055165 4816
2022-10-04 4 FORM 4 SUBMISSION 0001209191-22-052556 4816
2022-10-04 4 FORM 4 SUBMISSION 0001209191-22-052567 8799
2022-10-04 4 FORM 4 SUBMISSION 0001209191-22-052565 4851
2022-10-04 4 FORM 4 SUBMISSION 0001209191-22-052558 4885
2022-10-04 4 FORM 4 SUBMISSION 0001209191-22-052555 4882
2022-09-21 8-K 8-K 5.02,9.01 0000950170-22-018700 001-39787 221255092 34 383650 1 1
2022-09-20 4/A FORM 4/A SUBMISSION 0001209191-22-050774 3862
2022-09-20 3/A FORM 3/A SUBMISSION 0001209191-22-050771 3682
2022-09-15 4 FORM 4 SUBMISSION 0001209191-22-050147 5834
2022-09-01 4 FORM 4 SUBMISSION 0001209191-22-048367 8799
2022-09-01 4 FORM 4 SUBMISSION 0001209191-22-048366 4816
2022-09-01 4 FORM 4 SUBMISSION 0001209191-22-048364 4882
2022-09-01 4 FORM 4 SUBMISSION 0001209191-22-048363 4885
2022-09-01 4 FORM 4 SUBMISSION 0001209191-22-048362 4851
2022-08-15 4 FORM 4 SUBMISSION 0001209191-22-045810 8750
2022-08-09 10-Q 10-Q 0000950170-22-016149 001-39787 221149270 34 7227197 1 1
2022-08-09 8-K 8-K 2.02,9.01 0000950170-22-016024 001-39787 221148137 34 385042 1 1
2022-08-01 4 FORM 4 SUBMISSION 0001209191-22-043744 8799
2022-08-01 4 FORM 4 SUBMISSION 0001209191-22-043743 4882
2022-08-01 4 FORM 4 SUBMISSION 0001209191-22-043742 4816
2022-08-01 4 FORM 4 SUBMISSION 0001209191-22-043741 4885
2022-08-01 4 FORM 4 SUBMISSION 0001209191-22-043740 4851
2022-07-01 4 FORM 4 SUBMISSION 0001209191-22-040328 8799
2022-07-01 4 FORM 4 SUBMISSION 0001209191-22-040327 4882
2022-07-01 4 FORM 4 SUBMISSION 0001209191-22-040325 4816
2022-07-01 4 FORM 4 SUBMISSION 0001209191-22-040322 4885
2022-07-01 4 FORM 4 SUBMISSION 0001209191-22-040318 4851
2022-06-23 4 FORM 4 SUBMISSION 0001209191-22-038959 10924
2022-06-22 4 FORM 4 SUBMISSION 0000899243-22-023587 3619
2022-06-17 4 FORM 4 SUBMISSION 0001209191-22-038185 8586
2022-06-17 4/A FORM 4/A SUBMISSION 0001209191-22-038182 5951
2022-06-17 4 FORM 4 SUBMISSION 0001209191-22-038177 5374
2022-06-17 4 FORM 4 SUBMISSION 0001209191-22-038172 5501
2022-06-17 4 FORM 4 SUBMISSION 0001209191-22-038170 5352
2022-06-17 4 FORM 4 SUBMISSION 0001209191-22-038169 5362
2022-06-17 8-K 8-K 5.07 0000950170-22-011774 001-39787 221022520 34 183774 1 1
2022-06-10 SC 13G/A filing.txt 0000315066-22-001622 005-91930 221008002 34 7852
2022-06-09 4 FORM 4 SUBMISSION 0001209191-22-035350 8579
2022-06-06 8-K 8-K 5.02 0001193125-22-168316 001-39787 22998104 34 139226 1 1
2022-06-03 4 FORM 4 SUBMISSION 0001209191-22-034323 10569
2022-06-03 4/A FORM 4/A SUBMISSION 0001209191-22-034318 4656
2022-06-03 4/A FORM 4/A SUBMISSION 0001209191-22-034311 5379
2022-06-03 4 FORM 4 SUBMISSION 0001209191-22-034305 4815
2022-06-03 4 FORM 4 SUBMISSION 0001209191-22-034303 4881
2022-06-03 4 FORM 4 SUBMISSION 0001209191-22-034299 4884
2022-06-03 4 FORM 4 SUBMISSION 0001209191-22-034296 4850
2022-05-18 EFFECT xslEFFECTX01/primary_doc.xml POS AM,0001193125-22-153165,2022-05-18 9999999995-22-001521 333-262528 22941068 33 1681
2022-05-17 POS AM POS AM 0001193125-22-153165 333-262528 22936021 33 76511
2022-05-06 4 FORM 4 SUBMISSION 0001209191-22-027637 4936
2022-05-06 4 FORM 4 SUBMISSION 0001209191-22-027631 4870
2022-05-06 4 FORM 4 SUBMISSION 0001209191-22-027629 4939
2022-05-06 4 FORM 4 SUBMISSION 0001209191-22-027627 4905
2022-05-06 4 FORM 4 SUBMISSION 0001209191-22-027626 7774
2022-05-05 10-Q 10-Q 0000950170-22-007871 001-39787 22896913 34 6113286 1 1
2022-05-04 8-K 8-K 2.02,9.01 0000950170-22-007371 001-39787 22891417 34 343252 1 1
2022-04-28 SC 13G p425220sc13g.htm 0001214659-22-005979 005-91930 22866313 34 91172
2022-04-25 DEFA14A DEFA14A 0001193125-22-117688 001-39787 22850141 34 81786
2022-04-25 DEF 14A DEF 14A 0001193125-22-117564 001-39787 22849806 34 681973
2022-04-11 8-K 8-K 7.01,9.01 0001193125-22-101666 001-39787 22819813 34 7132152 1 1
2022-04-04 4 FORM 4 SUBMISSION 0001209191-22-022745 4936
2022-04-04 4 FORM 4 SUBMISSION 0001209191-22-022744 4870
2022-04-04 4 FORM 4 SUBMISSION 0001209191-22-022743 4939
2022-04-04 4 FORM 4 SUBMISSION 0001209191-22-022742 4905
2022-04-04 4 FORM 4 SUBMISSION 0001209191-22-022741 7774
2022-03-04 4 FORM 4 SUBMISSION 0001209191-22-016382 4936
2022-03-04 4 FORM 4 SUBMISSION 0001209191-22-016374 4932
2022-03-04 4 FORM 4 SUBMISSION 0001209191-22-016367 4939
2022-03-04 4 FORM 4 SUBMISSION 0001209191-22-016363 4905
2022-03-04 4 FORM 4 SUBMISSION 0001209191-22-016353 7774
2022-03-01 424B3 424B3 0000950170-22-002383 333-260440 22693561 33 5784106
2022-03-01 S-8 S-8 0001193125-22-058789 333-263120 22692934 33 72122
2022-03-01 POS AM POS AM 0001193125-22-058761 333-262528 22692832 33 255448
2022-02-28 10-K 10-K 0000950170-22-002303 001-39787 22690082 34 16736594 1 1
2022-02-28 POSASR POSASR 0001193125-22-057854 333-262528 22689345 33 303732
2022-02-25 8-K 8-K 5.02 0001193125-22-054400 001-39787 22679957 34 146094 1 1
2022-02-24 4 FORM 4 SUBMISSION 0001209191-22-012946 5541
2022-02-24 4 FORM 4 SUBMISSION 0001209191-22-012944 5554
2022-02-24 4 FORM 4 SUBMISSION 0001209191-22-012942 5539
2022-02-24 4 FORM 4 SUBMISSION 0001209191-22-012940 5533
2022-02-24 4 FORM 4 SUBMISSION 0001209191-22-012938 5509
2022-02-14 SC 13G/A JAY SHORT 13G 0001068238-22-000045 005-91930 22631894 34 97156
2022-02-14 SC 13G/A schedule13g.htm 0000929638-22-000479 005-91930 22630194 34 107864
2022-02-11 SC 13G/A SC 13G/A BIOATLA 0000078003-22-000012 005-91930 22622245 34 64010
2022-02-11 SC 13G/A SCHEDULE 13G/A 0001104659-22-020460 005-91930 22620683 34 35316
2022-02-09 SC 13G SCHEDULE 13G 0001104659-22-016639 005-91930 22606641 34 12857
2022-02-09 SC 13G/A filing.txt 0000315066-22-000769 005-91930 22604069 34 8383
2022-02-08 SC 13G/A AMENDMENT #1 0000908834-22-000047 005-91930 22599900 34 334558
2022-02-04 S-3ASR S-3ASR 0001193125-22-028341 333-262528 22593330 33 736069
2022-02-04 SC 13G SEC SCHEDULE 13G 0001678858-22-000117 005-91930 22591279 34 37784
2022-02-02 4 FORM 4 SUBMISSION 0001209191-22-006516 5512
2022-02-02 3 FORM 3 SUBMISSION 0001209191-22-006509 6832
2022-02-02 4 FORM 4 SUBMISSION 0001209191-22-006504 5017
2022-02-02 4 FORM 4 SUBMISSION 0001209191-22-006503 5011
2022-02-02 4 FORM 4 SUBMISSION 0001209191-22-006500 4884
2022-02-02 4 FORM 4 SUBMISSION 0001209191-22-006497 4850
2022-02-02 4 FORM 4 SUBMISSION 0001209191-22-006493 7719
2022-01-11 8-K 8-K 1.01,9.01 0000950170-22-000220 001-39787 22522169 34 196992 1 1
2022-01-05 4 FORM 4 SUBMISSION 0001209191-22-002043 4938
2022-01-05 4 FORM 4 SUBMISSION 0001209191-22-002042 4871
2022-01-05 4 FORM 4 SUBMISSION 0001209191-22-002040 4937
2022-01-05 4 FORM 4 SUBMISSION 0001209191-22-002039 4906
2022-01-05 4 FORM 4 SUBMISSION 0001209191-22-002038 7775
2021-12-21 8-K 8-K 5.02,9.01 0001193125-21-363150 001-39787 211507004 34 180469 1 1
2021-12-07 4 FORM 4 SUBMISSION 0001209191-21-068388 19034

Latest XBRL company facts

One latest value per concept from companyfacts (245 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 32.32M 2021-08-13 2021 Q2 10-Q 2021-08-13 0000950170-21-001443
dei EntityPublicFloat Entity Public Float USD 18.70M 2025-06-30 2025 FY 10-K/A 2026-04-29 0001193125-26-191493
ecd NonPeoNeoAvgCompActuallyPaidAmt NonPeoNeoAvgCompActuallyPaidAmt USD 555,106 2025-01-01 2025-12-31 DEF 14A 2026-06-03 0001193125-26-255422
ecd NonPeoNeoAvgTotalCompAmt NonPeoNeoAvgTotalCompAmt USD 550,294 2025-01-01 2025-12-31 DEF 14A 2026-06-03 0001193125-26-255422
ecd PeoActuallyPaidCompAmt PeoActuallyPaidCompAmt USD 866,130 2025-01-01 2025-12-31 DEF 14A 2026-06-03 0001193125-26-255422
ecd PeoTotalCompAmt PeoTotalCompAmt USD 879,248 2025-01-01 2025-12-31 DEF 14A 2026-06-03 0001193125-26-255422
ecd TotalShareholderRtnAmt TotalShareholderRtnAmt USD 6.88 2025-01-01 2025-12-31 DEF 14A 2026-06-03 0001193125-26-255422
ffd NetFeeAmt NetFeeAmt USD 925.4 2026-10-19 S-1 2026-10-20 0001539497-26-002711
ffd TtlFeeAmt TtlFeeAmt USD 925.4 2026-10-19 S-1 2026-10-20 0001539497-26-002711
ffd TtlOfferingAmt TtlOfferingAmt USD 10.64M 2026-10-19 S-1 2026-10-20 0001539497-26-002711
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-10-19 S-1 2026-10-20 0001539497-26-002711
ffd TtlPrevslyPdAmt TtlPrevslyPdAmt USD 0 2026-10-19 S-1 2026-10-20 0001539497-26-002711
us-gaap AccountsPayableAndAccruedLiabilitiesCurrent Accounts Payable and Accrued Liabilities, Current USD 18.86M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462306
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 12.49M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462306
us-gaap AccountsPayableCurrentAndNoncurrent Accounts Payable USD 0 2025-09-30 2025 Q3 10-Q 2025-11-13 0001193125-25-280435
us-gaap AccountsPayableOtherCurrent Accounts Payable, Other, Current USD 300,000 2026-06-30 S-1 2026-10-20 0001539497-26-002711
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 0 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462306
us-gaap AccruedLiabilitiesAndOtherLiabilities Accrued Liabilities and Other Liabilities USD 5.80M 2025-12-31 S-1 2026-10-20 0001539497-26-002711
us-gaap AccruedSalariesCurrent Accrued Salaries, Current USD 37,000 2025-12-31 S-1 2026-10-20 0001539497-26-002711
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 5.43M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462306
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 515.84M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462306
us-gaap AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature USD 534,000 2019-01-01 2019-12-31 2021 FY 10-K 2022-02-28 0000950170-22-002303
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 2.11M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462306
us-gaap AdjustmentsToAdditionalPaidInCapitalWarrantIssued Adjustments to Additional Paid in Capital, Warrant Issued USD 764,000 2019-01-01 2019-12-31 2021 FY 10-K 2022-02-28 0000950170-22-002303
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD -6.85M 2020-01-01 2020-12-31 2021 FY 10-K 2022-02-28 0000950170-22-002303
us-gaap AllocatedShareBasedCompensationExpenseNetOfTax Share-based Payment Arrangement, Expense, after Tax USD 294,000 2024-01-01 2024-12-31 S-1 2026-10-20 0001539497-26-002711
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 358,801 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462306
us-gaap AssetImpairmentCharges Asset Impairment Charges USD 4.90M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462306
us-gaap Assets Assets USD 1.11M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462306
us-gaap AssetsCurrent Assets, Current USD 946,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462306
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestructuringLiabilities Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Restructuring Liabilities USD 0 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134499
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 576,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462306
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 576,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462306
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect USD -6.54M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462306
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 Class of Warrant or Right, Exercise Price of Warrants or Rights USD/shares 4.35 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462306
us-gaap CommonStockCapitalSharesReservedForFutureIssuance Common Stock, Capital Shares Reserved for Future Issuance shares 457,997 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462306
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462306
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 350.00M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462306
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 1.67M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462306
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 1.67M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462306
us-gaap CommonStockValue Common Stock, Value, Issued USD 0 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462306
us-gaap DebtInstrumentDecreaseForgiveness Debt Instrument, Decrease, Forgiveness USD 700,000 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-15 0000950170-21-004617
us-gaap DebtInstrumentFairValue Debt Instrument, Fair Value Disclosure USD 4.10M 2025-12-31 S-1 2026-10-20 0001539497-26-002711
us-gaap DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction Debt Issuance Costs Incurred During Noncash or Partial Noncash Transaction USD 0 2021-01-01 2021-06-30 2021 Q2 10-Q 2021-08-13 0000950170-21-001443
us-gaap DeferredGainOnSaleOfProperty Deferred Gain on Sale of Property USD 1.49M 2025-12-31 S-1 2026-10-20 0001539497-26-002711
us-gaap DeferredIncomeTaxExpenseBenefit Deferred Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 S-1 2026-10-20 0001539497-26-002711
us-gaap DeferredRentCreditCurrent Deferred Rent Credit, Current USD 0 2021-12-31 2021 FY 10-K 2022-02-28 0000950170-22-002303
us-gaap DeferredRentCreditNoncurrent Deferred Rent Credit, Noncurrent USD 0 2021-12-31 2021 FY 10-K 2022-02-28 0000950170-22-002303
us-gaap DeferredRevenueCurrent Deferred Revenue, Current USD 0 2021-12-31 2021 FY 10-K 2022-02-28 0000950170-22-002303
us-gaap DeferredTaxAssetsDeferredIncome Deferred Tax Assets, Deferred Income USD 4.16M 2020-12-31 2021 FY 10-K 2022-02-28 0000950170-22-002303
us-gaap DeferredTaxAssetsGoodwillAndIntangibleAssets Deferred Tax Assets, Goodwill and Intangible Assets USD 2.43M 2025-12-31 S-1 2026-10-20 0001539497-26-002711
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 117.09M 2025-12-31 S-1 2026-10-20 0001539497-26-002711
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 0 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134499
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 1.16M 2025-12-31 S-1 2026-10-20 0001539497-26-002711
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 51.46M 2025-12-31 S-1 2026-10-20 0001539497-26-002711
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 81,000 2025-12-31 S-1 2026-10-20 0001539497-26-002711
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsResearch Deferred Tax Assets, Tax Credit Carryforwards, Research USD 15.42M 2025-12-31 S-1 2026-10-20 0001539497-26-002711
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Employee Compensation USD 556,000 2024-12-31 S-1 2026-10-20 0001539497-26-002711
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 3.63M 2025-12-31 S-1 2026-10-20 0001539497-26-002711
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Deferred Rent USD 504,000 2020-12-31 2021 FY 10-K 2022-02-28 0000950170-22-002303
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 115.93M 2025-12-31 S-1 2026-10-20 0001539497-26-002711
us-gaap DeferredTaxLiabilities Deferred Tax Liabilities, Net USD 1.16M 2025-12-31 S-1 2026-10-20 0001539497-26-002711
us-gaap DeferredTaxLiabilitiesLeasingArrangements Deferred Tax Liabilities, Leasing Arrangements USD 1.16M 2025-12-31 S-1 2026-10-20 0001539497-26-002711
us-gaap DeferredTaxLiabilitiesRegulatoryAssets Deferred Tax Liabilities, Regulatory Assets USD 75,000 2024-12-31 S-1 2026-10-20 0001539497-26-002711
us-gaap DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityBadDebtReserveForTaxPurposesOfQualifiedLender Deferred Tax Liability Not Recognized, Amount of Unrecognized Deferred Tax Liability, Bad Debt Reserve for Tax Purposes of Qualified Lender USD 4.16M 2025-12-31 S-1 2026-10-20 0001539497-26-002711
us-gaap DefinedContributionPlanCostRecognized Defined Contribution Plan, Cost USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462306
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 120,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462306
us-gaap DerivativeAssetFairValueGrossLiability Derivative Asset, Fair Value, Gross Liability USD 0 2023-12-31 2023 FY 10-K 2024-03-26 0000950170-24-036548
us-gaap DerivativeFairValueOfDerivativeAsset Derivative Asset, Fair Value, Gross Asset USD 0 2023-12-31 2023 FY 10-K 2024-03-26 0000950170-24-036548
us-gaap DerivativeFloorPrice Derivative, Floor Price USD/XUA 0.23 2025-11-30 2025 FY 10-K 2026-03-31 0001193125-26-134499
us-gaap DerivativeGainLossOnDerivativeNet Derivative, Gain (Loss) on Derivative, Net USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-02-28 0000950170-22-002303
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -8.56 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462306
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -0.65 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-05 0000950170-22-007871
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -8.56 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462306
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0 2025-01-01 2025-12-31 S-1 2026-10-20 0001539497-26-002711
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 S-1 2026-10-20 0001539497-26-002711
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.215 2025-01-01 2025-12-31 S-1 2026-10-20 0001539497-26-002711
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpense Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent pure -0.016 2025-01-01 2025-12-31 S-1 2026-10-20 0001539497-26-002711
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent pure -0.007 2025-01-01 2025-12-31 S-1 2026-10-20 0001539497-26-002711
us-gaap EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent pure 0 2025-01-01 2025-12-31 S-1 2026-10-20 0001539497-26-002711
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0 2025-01-01 2025-12-31 S-1 2026-10-20 0001539497-26-002711
us-gaap EffectiveIncomeTaxRateReconciliationTaxContingencies Effective Income Tax Rate Reconciliation, Tax Contingency, Percent pure 0 2025-01-01 2025-12-31 S-1 2026-10-20 0001539497-26-002711
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent pure 0.021 2025-01-01 2025-12-31 S-1 2026-10-20 0001539497-26-002711
us-gaap EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability Embedded Derivative, Fair Value of Embedded Derivative Liability USD 0 2020-12-31 2021 FY 10-K 2022-02-28 0000950170-22-002303
us-gaap EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet Embedded Derivative, Gain (Loss) on Embedded Derivative, Net USD 1.58M 2020-01-01 2020-12-31 2021 FY 10-K 2022-02-28 0000950170-22-002303
us-gaap FairValueAdjustmentOfWarrants Fair Value Adjustment of Warrants USD -3.35M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462306
us-gaap GainLossOnSaleOfPropertyPlantEquipment Gain (Loss) on Disposition of Property Plant Equipment USD -185,000 2025-01-01 2025-12-31 S-1 2026-10-20 0001539497-26-002711
us-gaap GainsLossesOnExtinguishmentOfDebt Gain (Loss) on Extinguishment of Debt USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-23 0000950170-23-009551
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 9.99M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462306
us-gaap ImpairmentOfLongLivedAssetsHeldForUse Impairment of Long-Lived Assets Held-for-use USD 0 2025-01-01 2025-12-31 S-1 2026-10-20 0001539497-26-002711
us-gaap IncomeTaxesPaid Income Taxes Paid USD 0 2025-01-01 2025-12-31 S-1 2026-10-20 0001539497-26-002711
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 S-1 2026-10-20 0001539497-26-002711
us-gaap IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability Income Tax Expense (Benefit), Continuing Operations, Adjustment of Deferred Tax (Asset) Liability USD -2.13M 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-23 0000950170-23-009551
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 12.83M 2025-01-01 2025-12-31 S-1 2026-10-20 0001539497-26-002711
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -12.52M 2025-01-01 2025-12-31 S-1 2026-10-20 0001539497-26-002711
us-gaap IncomeTaxReconciliationNondeductibleExpense Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount USD 981,000 2025-01-01 2025-12-31 S-1 2026-10-20 0001539497-26-002711
us-gaap IncomeTaxReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount USD -132,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-28 0000950170-25-046217
us-gaap IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Amount USD 3.79M 2024-01-01 2024-12-31 S-1 2026-10-20 0001539497-26-002711
us-gaap IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount USD 403,000 2025-01-01 2025-12-31 S-1 2026-10-20 0001539497-26-002711
us-gaap IncomeTaxReconciliationOtherReconcilingItems Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount USD 0 2025-01-01 2025-12-31 S-1 2026-10-20 0001539497-26-002711
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD 0 2025-01-01 2025-12-31 S-1 2026-10-20 0001539497-26-002711
us-gaap IncomeTaxReconciliationTaxContingencies Effective Income Tax Rate Reconciliation, Tax Contingency, Amount USD 0 2025-01-01 2025-12-31 S-1 2026-10-20 0001539497-26-002711
us-gaap IncomeTaxReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount USD -1.28M 2025-01-01 2025-12-31 S-1 2026-10-20 0001539497-26-002711
us-gaap IncreaseDecreaseInAccountsPayableAndAccruedLiabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities USD 2.79M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462306
us-gaap IncreaseDecreaseInAccountsPayableRelatedParties Increase (Decrease) in Accounts Payable, Related Parties USD 300,000 2026-01-01 2026-06-30 S-1 2026-10-20 0001539497-26-002711
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD 2.00M 2026-01-01 2026-06-30 S-1 2026-10-20 0001539497-26-002711
us-gaap IncreaseDecreaseInAccruedInterestReceivableNet Increase (Decrease) in Accrued Interest Receivable, Net USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-23 0000950170-23-009551
us-gaap IncreaseDecreaseInDeferredRevenue Increase (Decrease) in Deferred Revenue USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-02-28 0000950170-22-002303
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD 348,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462306
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD -525,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462306
us-gaap IncrementalCommonSharesAttributableToShareBasedPaymentArrangements Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements shares 1,123 2026-04-01 2026-06-30 S-1 2026-10-20 0001539497-26-002711
us-gaap InterestExpense Interest Expense USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-23 0000950170-23-009551
us-gaap InterestExpenseRelatedParty Interest Expense, Related Party USD 0 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-15 0000950170-21-004617
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 65,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462306
us-gaap LeaseCost Lease, Cost USD 1.37M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462306
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 7.00M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462306
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive Lessee, Operating Lease, Liability, to be Paid, after Year Five USD 1.53M 2025-09-30 2025 Q3 10-Q 2025-11-13 0001193125-25-280435
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 753,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462306
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 1.53M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462306
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 1.62M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462306
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 1.57M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462306
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 1.53M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462306
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 1.13M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462306
us-gaap Liabilities Liabilities USD 44.70M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462306
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 1.11M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462306
us-gaap LiabilitiesCurrent Liabilities, Current USD 20.69M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462306
us-gaap MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders USD 19,000 2020-01-01 2020-12-31 2021 FY 10-K 2022-02-28 0000950170-22-002303
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 111,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462306
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD 0 2025-01-01 2025-03-31 2025 Q1 10-Q 2025-05-06 0000950170-25-064594
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -6.65M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462306
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -13.79M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462306
us-gaap NetIncomeLossAttributableToNoncontrollingInterest Net Income (Loss) Attributable to Noncontrolling Interest USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-02-28 0000950170-22-002303
us-gaap NetIncomeLossAttributableToRedeemableNoncontrollingInterest Net Income (Loss) Attributable to Redeemable Noncontrolling Interest USD -28.73M 2019-01-01 2019-12-31 2021 FY 10-K 2022-02-28 0000950170-22-002303
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -72.01M 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-15 0000950170-21-004617
us-gaap NumberOfOperatingSegments Number of Operating Segments NumberOfSegment 1 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-26 0000950170-24-036548
us-gaap OperatingExpenses Operating Expenses USD 24.19M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462306
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -17.44M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462306
us-gaap OperatingLeaseCost Operating Lease, Cost USD 1.08M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462306
us-gaap OperatingLeaseExpense Operating Lease, Expense USD 1.70M 2021-01-01 2021-12-31 2021 FY 10-K 2022-02-28 0000950170-22-002303
us-gaap OperatingLeaseImpairmentLoss Operating Lease, Impairment Loss USD 4.86M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462306
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 5.87M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462306
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 1.83M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462306
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 4.04M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462306
us-gaap OperatingLeasePayments Operating Lease, Payments USD 731,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462306
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 0 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462306
us-gaap OperatingLeasesFutureMinimumPaymentsDue Operating Leases, Future Minimum Payments Due USD 6.09M 2021-09-30 2021 Q3 10-Q 2021-11-15 0000950170-21-004617
us-gaap OperatingLeasesFutureMinimumPaymentsDueCurrent Operating Leases, Future Minimum Payments Due, Next Twelve Months USD 1.55M 2021-09-30 2021 Q3 10-Q 2021-11-15 0000950170-21-004617
us-gaap OperatingLeasesFutureMinimumPaymentsDueInThreeYears Operating Leases, Future Minimum Payments, Due in Three Years USD 1.69M 2021-09-30 2021 Q3 10-Q 2021-11-15 0000950170-21-004617
us-gaap OperatingLeasesFutureMinimumPaymentsDueInTwoYears Operating Leases, Future Minimum Payments, Due in Two Years USD 1.64M 2021-09-30 2021 Q3 10-Q 2021-11-15 0000950170-21-004617
us-gaap OperatingLeasesFutureMinimumPaymentsDueThereafter Operating Leases, Future Minimum Payments, Due Thereafter USD 845,000 2021-09-30 2021 Q3 10-Q 2021-11-15 0000950170-21-004617
us-gaap OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear Operating Leases, Future Minimum Payments, Remainder of Fiscal Year USD 370,000 2021-09-30 2021 Q3 10-Q 2021-11-15 0000950170-21-004617
us-gaap OperatingLeasesRentExpenseNet Operating Leases, Rent Expense, Net USD 1.20M 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-15 0000950170-21-004617
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.09 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462306
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 112,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462306
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 163,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462306
us-gaap OtherExpenses Other Expenses USD 39,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462306
us-gaap OtherLongTermDebtNoncurrent Other Long-term Debt, Noncurrent USD 0 2021-12-31 2021 FY 10-K 2022-02-28 0000950170-22-002303
us-gaap OtherNoncashExpense Other Noncash Expense USD 0 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-15 0000950170-21-004617
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD 3.65M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462306
us-gaap PaidInKindInterest Paid-in-Kind Interest USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-02-28 0000950170-22-002303
us-gaap PaymentsForRepurchaseOfInitialPublicOffering Payments for Repurchase of Initial Public Offering USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-23 0000950170-23-009551
us-gaap PaymentsForRestructuring Payments for Restructuring USD 500,000 2026-01-01 2026-03-31 2026 Q3 10-Q 2026-11-16 0001193125-26-462306
us-gaap PaymentsOfDebtIssuanceCosts Payments of Debt Issuance Costs USD 700,000 2025-01-01 2025-12-31 2026 Q3 10-Q 2026-11-16 0001193125-26-462306
us-gaap PaymentsOfFinancingCosts Payments of Financing Costs USD 289,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462306
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 3.32M 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-26 0000950170-24-036548
us-gaap PaymentsToAcquireMachineryAndEquipment Payments to Acquire Machinery and Equipment USD 0 2025-01-01 2025-03-31 2025 Q1 10-Q 2025-05-06 0000950170-25-064594
us-gaap PaymentsToMinorityShareholders Payments to Noncontrolling Interests USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-02-28 0000950170-22-002303
us-gaap PreferredStockDividendRatePercentage Preferred Stock, Dividend Rate, Percentage pure 0.1 2021-01-01 2021-12-31 2021 FY 10-K 2022-02-28 0000950170-22-002303
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462306
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 200.00M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462306
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462306
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462306
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462306
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 370,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462306
us-gaap PrepaidInsurance Prepaid Insurance USD 111,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462306
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-02-28 0000950170-22-002303
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134499
us-gaap ProceedsFromIssuanceOfConvertiblePreferredStock Proceeds from Issuance of Convertible Preferred Stock USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-02-28 0000950170-22-002303
us-gaap ProceedsFromIssuanceOfDebt Proceeds from Issuance of Debt USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-02-28 0000950170-22-002303
us-gaap ProceedsFromIssuanceOfOtherLongTermDebt Proceeds from Issuance of Other Long-term Debt USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-02-28 0000950170-22-002303
us-gaap ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans Proceeds, Issuance of Shares, Share-based Payment Arrangement, Excluding Option Exercised USD 3,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462306
us-gaap ProceedsFromSaleOfOtherPropertyPlantAndEquipment Proceeds from Sale of Other Property, Plant, and Equipment USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-26 0000950170-24-036548
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-23 0000950170-23-009551
us-gaap PropertyPlantAndEquipmentAdditions Property, Plant and Equipment, Additions USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-26 0000950170-24-036548
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 5.43M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462306
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 0 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462306
us-gaap RelatedPartyTransactionAmountsOfTransaction Related Party Transaction, Amounts of Transaction USD 975,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462306
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 9.34M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462306
us-gaap RestrictedCashEquivalents Restricted Cash Equivalents USD 42.30M 2024-09-30 2024 Q3 10-Q 2024-11-07 0000950170-24-123506
us-gaap RestructuringCharges Restructuring Charges USD 556,000 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-07 0000950170-25-105220
us-gaap RestructuringCosts Restructuring Costs USD 500,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462306
us-gaap RestructuringReserve Restructuring Reserve USD 0 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462306
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -559.43M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462306
us-gaap RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer Revenue from Collaborative Arrangement, Excluding Revenue from Contract with Customer USD 6.75M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462306
us-gaap Revenues Revenues USD 0 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-07 0000950170-23-060389
us-gaap SettlementLiabilitiesCurrent Settlement Liabilities, Current USD 4.50M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462306
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 2.11M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462306
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134499
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 0.953 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134499
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.037 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134499
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 0 2022-12-31 2022 FY 10-K 2023-03-23 0000950170-23-009551
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 496,074 2022-12-31 2022 FY 10-K 2023-03-23 0000950170-23-009551
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 25.95 2022-12-31 2022 FY 10-K 2023-03-23 0000950170-23-009551
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value USD 182.83M 2021-01-01 2021-12-31 2021 FY 10-K 2022-02-28 0000950170-22-002303
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period shares 112,367 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-26 0000950170-24-036548
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period shares 170,836 2020-01-01 2020-12-31 2021 FY 10-K 2022-02-28 0000950170-22-002303
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 371,439 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-26 0000950170-24-036548
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 479,543 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-23 0000950170-23-009551
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares shares 0 2020-12-31 2021 FY 10-K 2022-02-28 0000950170-22-002303
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Number of Shares shares 170,836 2020-01-01 2020-12-31 2021 FY 10-K 2022-02-28 0000950170-22-002303
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 991.50M 2021-12-31 2022 FY 10-K 2023-03-23 0000950170-23-009551
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 6.27M 2023-12-31 2023 FY 10-K 2024-03-26 0000950170-24-036548
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 26.76 2021-12-31 2022 FY 10-K 2023-03-23 0000950170-23-009551
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value USD 3.64B 2022-12-31 2022 FY 10-K 2023-03-23 0000950170-23-009551
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number shares 6.27M 2023-12-31 2023 FY 10-K 2024-03-26 0000950170-24-036548
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price USD/shares 13.82 2022-12-31 2022 FY 10-K 2023-03-23 0000950170-23-009551
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value USD 1.30M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462306
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares shares 1.31M 2020-01-01 2020-12-31 2021 FY 10-K 2022-02-28 0000950170-22-002303
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent pure 0.15 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-04 0000950170-22-022036
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-23 0000950170-23-009551
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price USD/shares 40 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-23 0000950170-23-009551
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 21.64 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-23 0000950170-23-009551
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 37.86 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-23 0000950170-23-009551
us-gaap SharesIssuedPricePerShare Shares Issued, Price Per Share USD/shares 69.5 2025-11-30 S-1 2026-10-20 0001539497-26-002711
us-gaap SharesOutstanding Shares, Outstanding shares 1.49M 2022-06-30 2023 Q2 10-Q 2023-08-01 0000950170-23-036554
us-gaap StockGrantedDuringPeriodValueSharebasedCompensationForfeited Shares Granted, Value, Share-based Payment Arrangement, Forfeited USD 25,000 2019-11-01 2019-11-30 2021 FY 10-K 2022-02-28 0000950170-22-002303
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD -43.60M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462306
us-gaap StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest USD -43.60M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462306
us-gaap StockholdersEquityNoteStockSplitConversionRatio1 Stockholders' Equity Note, Stock Split, Conversion Ratio pure 50 2026-04-06 2026 Q3 10-Q 2026-11-16 0001193125-26-462306
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-26 0000950170-24-036548
us-gaap StockIssuedDuringPeriodValueEmployeeStockPurchasePlan Stock Issued During Period, Value, Employee Stock Purchase Plan USD 3,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462306
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 61.68M 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-26 0000950170-24-036548
us-gaap StockIssuedDuringPeriodValueShareBasedCompensation Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-02-28 0000950170-22-002303
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 140,000 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-23 0000950170-23-009551
us-gaap TaxCreditCarryforwardAmount Tax Credit Carryforward, Amount USD 11.80M 2025-12-31 S-1 2026-10-20 0001539497-26-002711
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 5.35M 2025-12-31 S-1 2026-10-20 0001539497-26-002711
us-gaap UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions Unrecognized Tax Benefits, Decrease Resulting from Current Period Tax Positions USD 947,000 2024-01-01 2024-12-31 S-1 2026-10-20 0001539497-26-002711
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions USD 717,000 2025-01-01 2025-12-31 S-1 2026-10-20 0001539497-26-002711
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions USD 52,000 2025-01-01 2025-12-31 S-1 2026-10-20 0001539497-26-002711
us-gaap UnrecognizedTaxBenefitsPeriodIncreaseDecrease Unrecognized Tax Benefits, Period Increase (Decrease) USD 1.55M 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-26 0000950170-24-036548
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 13.30M 2025-01-01 2025-12-31 S-1 2026-10-20 0001539497-26-002711
us-gaap VariableLeaseCost Variable Lease, Cost USD 295,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462306
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 1.61M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462306
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 37.32M 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-05 0000950170-22-007871
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 1.61M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462306

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →